A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers

Clinical trial NCT06805617 · RECRUITING

Trial details

NCT number: NCT06805617
Sponsor: Glenn J. Hanna
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Salivary Gland Cancer Advanced Salivary Gland Carcinoma Metastatic Salivary Gland Cancer Adenoid Cystic Carcinoma

Start date: 2025-02-26
Primary completion: 2026-07-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.